DENTSPLY SIRONA (NASDAQ:XRAY) Upgraded at StockNews.com

by · The Cerbat Gem

DENTSPLY SIRONA (NASDAQ:XRAY – Get Free Report) was upgraded by investment analysts at StockNews.com from a “hold” rating to a “buy” rating in a research note issued on Monday.

A number of other brokerages also recently commented on XRAY. Needham & Company LLC reduced their price target on DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating for the company in a report on Friday. Robert W. Baird decreased their price target on shares of DENTSPLY SIRONA from $33.00 to $31.00 and set a “neutral” rating for the company in a research report on Monday, July 22nd. Stifel Nicolaus dropped their price target on shares of DENTSPLY SIRONA from $30.00 to $28.00 and set a “hold” rating for the company in a research note on Thursday, July 18th. Evercore ISI reduced their price objective on shares of DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating on the stock in a research note on Tuesday, October 8th. Finally, Barrington Research reissued an “outperform” rating and issued a $36.00 target price on shares of DENTSPLY SIRONA in a research report on Friday, September 20th. Four research analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $32.67.

Check Out Our Latest Research Report on DENTSPLY SIRONA

DENTSPLY SIRONA Stock Up 1.3 %

Shares of XRAY traded up $0.30 during mid-day trading on Monday, reaching $23.61. 1,742,235 shares of the stock traded hands, compared to its average volume of 2,959,859. The stock has a fifty day simple moving average of $25.22 and a 200 day simple moving average of $26.43. DENTSPLY SIRONA has a 12-month low of $22.85 and a 12-month high of $37.60. The company has a quick ratio of 0.87, a current ratio of 1.33 and a debt-to-equity ratio of 0.57. The firm has a market cap of $4.79 billion, a price-to-earnings ratio of -27.45, a P/E/G ratio of 1.12 and a beta of 1.00.

DENTSPLY SIRONA (NASDAQ:XRAY – Get Free Report) last released its quarterly earnings results on Wednesday, July 31st. The medical instruments supplier reported $0.49 earnings per share for the quarter, missing analysts’ consensus estimates of $0.50 by ($0.01). The firm had revenue of $984.00 million for the quarter, compared to analyst estimates of $993.61 million. DENTSPLY SIRONA had a negative net margin of 4.75% and a positive return on equity of 11.86%. DENTSPLY SIRONA’s revenue for the quarter was down 4.3% on a year-over-year basis. During the same period in the previous year, the business posted $0.51 earnings per share. Sell-side analysts expect that DENTSPLY SIRONA will post 1.98 EPS for the current fiscal year.

Institutional Trading of DENTSPLY SIRONA

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. First Eagle Investment Management LLC grew its stake in DENTSPLY SIRONA by 33.6% during the 2nd quarter. First Eagle Investment Management LLC now owns 13,069,900 shares of the medical instruments supplier’s stock worth $325,571,000 after buying an additional 3,283,965 shares during the last quarter. SG Americas Securities LLC grew its position in shares of DENTSPLY SIRONA by 2,959.1% during the first quarter. SG Americas Securities LLC now owns 1,373,421 shares of the medical instruments supplier’s stock worth $45,584,000 after acquiring an additional 1,328,525 shares during the last quarter. Dimensional Fund Advisors LP increased its holdings in shares of DENTSPLY SIRONA by 42.0% in the 2nd quarter. Dimensional Fund Advisors LP now owns 4,420,445 shares of the medical instruments supplier’s stock worth $110,118,000 after acquiring an additional 1,308,411 shares during the period. Cooke & Bieler LP lifted its position in DENTSPLY SIRONA by 16.2% in the 2nd quarter. Cooke & Bieler LP now owns 7,506,845 shares of the medical instruments supplier’s stock valued at $186,996,000 after purchasing an additional 1,046,105 shares during the last quarter. Finally, Edmond DE Rothschild Holding S.A. lifted its position in DENTSPLY SIRONA by 398.2% in the 1st quarter. Edmond DE Rothschild Holding S.A. now owns 1,025,200 shares of the medical instruments supplier’s stock valued at $34,026,000 after purchasing an additional 819,400 shares during the last quarter. 95.70% of the stock is currently owned by institutional investors and hedge funds.

About DENTSPLY SIRONA

(Get Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Further Reading